The lack of information about autism’s manifestation in girls means many are never diagnosed and miss out on beneficial interventions, UVA's Kevin Pelphrey fears.
UVA Health is launching a clinical trial with local emergency service providers to determine whether an investigational new drug, trans sodium crocetinate (TSC), can improve patient outcomes when administered at the first signs of a stroke.